SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-19-040158
Filing Date
2019-02-14
Accepted
2019-02-14 13:45:02
Documents
1
Group Members
QVT ASSOCIATES GP LLCQVT FAMILY OFFICE FUND LPQVT FINANCIAL GP LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G AMENDMENT NO. 2 d672802dsc13ga.htm SC 13G/A 90904
  Complete submission text file 0001193125-19-040158.txt   92484
Mailing Address 444 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 444 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022 212-705-8800
QVT Financial LP (Filed by) CIK: 0001290162 (see all company filings)

IRS No.: 113694008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS (441) 824-8101
Myovant Sciences Ltd. (Subject) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-89732 | Film No.: 19604210
SIC: 2834 Pharmaceutical Preparations